Isatoribine, a toll-like receptor 7 agonist, significantly reduced plasma viral load in a clinical proof-of-concept study in patients with chronic hepatitis C virus infection.

Horsmans, Yves;Berg, T.;Desager, Jean-Pierre;Muller, T.;Averett, D;et.al.
(2004) 55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) — Location: Boston (Ma) (29.October.2004)

Files

No attached file found for this publication.

Details

Authors
  • Horsmans, YvesUCLouvain
    Author
  • Berg, T.
    Author
  • Desager, Jean-PierreUCLouvain
    Author
  • Muller, T.
    Author
  • Averett, D
    Author
Show more
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Horsmans, Y., Berg, T., Desager, J.-P., Muller, T., Schott, E., Bauman, L., Steffy, K., Fletcher, S., Banh, V., Liaw, W., Kerr, B., & Averett, D. (2004). Isatoribine, a toll-like receptor 7 agonist, significantly reduced plasma viral load in a clinical proof-of-concept study in patients with chronic hepatitis C virus infection. Hepatology, 40(4), 282A-283A. https://hdl.handle.net/2078.5/140947 (Original work published 2004)